Synthetic applications of chiral 2,3-dihydro-4-pyridones
Joseph, S.; Comins, D.L.
Current Opinion in Drug Discovery and Development 5(6): 870-880
2002
ISSN/ISBN: 1367-6733 PMID: 12478718 Document Number: 545117
During the last decade, 2,3-dihydro-4-pyridones have become important intermediates for the synthesis of various alkaloids and biologically active compounds. The versatility of these heterocyclic building blocks has been demonstrated by the synthesis of several complex natural products. This review will cover recent work on the synthesis of substituted dihydropyridones, and their application in the synthesis of complex molecules.
Document emailed within 1 workday
Related Documents
Huang, X.-D.; Zou, H.-F.; Mao, X.-Q.; Luo, Q.-Z.; Chen, X.-M.; Xiao, X.-Z. 2002: Preparation of molecularly imprinted chiral monolithic column and its applications for separation of diastereomers Se Pu 20(5): 436-438Pirtskhalava, M.; Egoyan, A.; Mirtskhulava, M.; Roviello, G. 2017: A Computer Modeling Study of Binding Properties of Chiral Nucleopeptide for Biomedical Applications Georgian Medical News 273: 1123-1128
Hou, J.; Zhou, Z.; Chen, L.; Ou, Q. 1997: Brush-type chiral stationary phase for chiral resolution in high performance liquid chromatography Se Pu 15(3): 206-211
Ding, G.; Liu, Y.; Cong, R.; Wang, J. 2004: Chiral separation of beta-receptor blockers and analogs on novel norvancomycin-bonded chiral stationary phase Se Pu 22(4): 386-389
Ferri, V.; Pallavicini, M.; Piccini, D.; Valoti, E.; Villa, L.; Brunello, N.; Racagni, G. 1988: Synthesis, binding affinities for alpha-adrenoceptor and eudismic analysis of chiral benzodioxane derivatives and their chiral opened analogues Il Farmaco; Edizione Scientifica 43(12 Suppl): 1153-1163
Tang, L.; Xiang, D.; Blackwell, J.A. 2000: A comparative study of factors affecting chiral separations under reversed-phase conditions using cellulosic and Pirkle-type chiral selectors Enantiomer 5(3-4): 345-355
Haginaka, J.; Matsunaga, H. 2000: Separation of enantiomers on HPLC chiral stationary phases based on human plasma alpha1-acid glycoprotein: effect of sugar moiety on chiral recognition ability Enantiomer 5(1): 37-45
2015: First edition of nursing award 2014 on applications of a synthetic matrix of polymers powder formulated for wound healing Revista de Enfermeria 38(5): 75
Ashman, A. 1993: Clinical applications of synthetic bone in dentistry, Part II: Periodontal and bony defects in conjunction with dental implants General Dentistry 41(1): 37-44
Im, C.; Knaus, E.E.; Thuynsma, R.P.; Allen, T.M. 1990: Synthesis and cytotoxic activity of (E)-1-(2-nitrovinyl) and 1-[N-(tert-butylformiminyl)]-substituted 1,4-dihydropyridines and 2-pyridones Drug Design and Delivery 5(3): 239-248
Alder, J.; Clement, J.; Meulbroek, J.; Shipkowitz, N.; Mitten, M.; Jarvis, K.; Oleksijew, A.; Hutch, T.; Paige, L.; Flamm, B. 1995: Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infections Antimicrobial Agents and ChemoTherapy 39(4): 971-975
Reisner, D.B.; Ludwig, B.J.; Simon, E.; Dejneka, T.; Sofia, R.D. 1977: 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino [3,2-b]quinazolin-10(2H)-ones Arzneimittel-Forschung 27(4): 766-770
Bianco, T.; Centore, R.; Giannetti, P.; Scuri, R. 1992: Compared kinetics of 2-(2,3-dihydro-5-acetoxy-4,6,7-trimethylbenzofuranyl) acetic acid (IRFI 016) and its active metabolite 2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) acetic acid (IRFI 005) in plasma and bronchial alveolar liquid in mice Drugs under Experimental and Clinical Research 18(3): 93-97
Wagner, G.; Wunderlich, I. 1976: Synthesis of N-[amidinobenzyl]-2-pyridones and 2-quinolines as well as of N-[amidinobenzyl]-4-aminopyridinium salts Die Pharmazie 31(11): 766-770
Hijikata, A.; Okamoto, S.; Kikumoto, R.; Tamao, Y. 1979: Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates Thrombosis and Haemostasis 42(3): 1039-1045
Bruno, O.; Ranise, A.; Bondavalli, F.; Schenone, P.; D'Amico, M.; Filippelli, A.; Filippelli, W.; Rossi, F. 1993: 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities Farmaco 48(7): 949-966
al Jarallah, A.S.; Duncan, W.J.; Broecker, L.; Allen, L.; Cornel, G. 1997: The Hemopump as a left ventricular assist device in pediatric applications: initial Canadian applications Canadian Journal of Cardiology 13(5): 489-494
Li, X.; Zeng, S. 1998: Chiral ion-pair chromatography Se Pu 16(2): 118-122
Bernareggi, A. 1995: Pharmacokinetics of chiral drugs Bollettino Chimico Farmaceutico 134(2): 63-68
Schumacher, G.E. 1981: Pharmacokinetic concepts and applications affecting the clinical laboratory: I. General concepts and applications American Journal of Medical Technology 47(3): 157-161